BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8371776)

  • 1. Antigen processing. Peptides and the proteasome.
    Howard JC; Seelig A
    Nature; 1993 Sep; 365(6443):211-2. PubMed ID: 8371776
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteases, proteases and proteases for presentation.
    Herberts C; Reits E; Neefjes J
    Nat Immunol; 2003 Apr; 4(4):306-8. PubMed ID: 12660727
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advance in the study on the proteasome activator PA28].
    Murata S; Chiba T
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1832-40. PubMed ID: 10936967
    [No Abstract]   [Full Text] [Related]  

  • 4. The components of the proteasome system and their role in MHC class I antigen processing.
    Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
    Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
    Gaczynska M; Rock KL; Goldberg AL
    Nature; 1993 Sep; 365(6443):264-7. PubMed ID: 8396732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
    Rock KL; York IA; Goldberg AL
    Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proteasome inhibitors to examine processing of antigens for major histocompatibility complex class I presentation.
    Antón LC; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():17-31. PubMed ID: 11068747
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigen processing by the proteasome.
    Kloetzel PM
    Nat Rev Mol Cell Biol; 2001 Mar; 2(3):179-87. PubMed ID: 11265247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proteolytic system that compensates for loss of proteasome function.
    Glas R; Bogyo M; McMaster JS; Gaczynska M; Ploegh HL
    Nature; 1998 Apr; 392(6676):618-22. PubMed ID: 9560160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading.
    Benham AM; Grommé M; Neefjes J
    J Immunol; 1998 Jul; 161(1):83-9. PubMed ID: 9647210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The proteasome: destroy to live].
    Abramova EB; Sharova NP; Karpov VL
    Mol Biol (Mosk); 2002; 36(5):761-76. PubMed ID: 12391838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.
    Driscoll J; Brown MG; Finley D; Monaco JJ
    Nature; 1993 Sep; 365(6443):262-4. PubMed ID: 8371781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
    J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitors and antigen presentation.
    Bogyo M; Gaczynska M; Ploegh HL
    Biopolymers; 1997; 43(4):269-80. PubMed ID: 9316392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of the fitters.
    Rammensee HG
    Nature; 2002 Oct; 419(6906):443-5. PubMed ID: 12368840
    [No Abstract]   [Full Text] [Related]  

  • 16. LMP2 expression and proteasome activity in NOD mice.
    Kessler BM; Lennon-Duménil AM; Shinohara ML; Lipes MA; Ploegh HL
    Nat Med; 2000 Oct; 6(10):1064; author reply 1065-6. PubMed ID: 11017111
    [No Abstract]   [Full Text] [Related]  

  • 17. The ubiquitin-proteasome pathway: on protein death and cell life.
    Ciechanover A
    EMBO J; 1998 Dec; 17(24):7151-60. PubMed ID: 9857172
    [No Abstract]   [Full Text] [Related]  

  • 18. Insights from MHC-bound peptides.
    Margalit H; Altuvia Y
    Novartis Found Symp; 2003; 254():77-90; discussion 91-101, 216-22, 250-2. PubMed ID: 14712933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
    Rechsteiner M; Realini C; Ustrell V
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterization.
    Eleuteri AM; Cuccioloni M; Bellesi J; Lupidi G; Fioretti E; Angeletti M
    Proteins; 2002 Aug; 48(2):169-77. PubMed ID: 12112686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.